Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Cash from Investing Activities (2022 - 2025)

Core Laboratories (CLB) has 4 years of Cash from Investing Activities data on record, last reported at $2.4 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 587.37% year-over-year to $2.4 million; the TTM value through Sep 2025 reached -$2.0 million, up 61.41%, while the annual FY2024 figure was -$6.4 million, 3.88% up from the prior year.
  • Cash from Investing Activities reached $2.4 million in Q3 2025 per CLB's latest filing, up from -$1.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.4 million in Q3 2025 and bottomed at -$3.6 million in Q4 2024.
  • Average Cash from Investing Activities over 4 years is -$1.0 million, with a median of -$1.6 million recorded in 2025.
  • Peak YoY movement for Cash from Investing Activities: crashed 331.19% in 2023, then soared 587.37% in 2025.
  • A 4-year view of Cash from Investing Activities shows it stood at $1.1 million in 2022, then crashed by 331.19% to -$2.4 million in 2023, then tumbled by 45.5% to -$3.6 million in 2024, then surged by 167.24% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $2.4 million in Q3 2025, -$1.6 million in Q2 2025, and $772000.0 in Q1 2025.